Literature DB >> 12969807

Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia.

Mar Bellido1, Anna Aventín, Adriana Lasa, Camino Estivill, Maria J Carnicer, Cristina Pons, Xavier Matías-Guiu, Ramón Bordes, Montserrat Baiget, Jorge Sierra, Josep F Nomdedéu.   

Abstract

BACKGROUND AND OBJECTIVES: Chromosome translocations resulting in gene overexpression are commonly associated with lymphoid neoplasia. Enhancer elements of the immunoglobulin or T-cell receptor (TCR) loci are abnormally located in the vicinity of the entire coding sequences of genes which exert an influence on the normal maturation and differentiation program of lymphoid cells. DESIGN AND METHODS: A patient who presented with a B-cell lineage acute lymphoblastic leukemia had a t(6;14)(p22;q32). Cytogenetic and molecular findings confirmed the involvement of IgH. Molecular cloning of the breakpoint revealed that this was located near the coding sequence of the Id4 gene, a helix-loop-helix (HLH) inhibitor protein. Alu-repeated sequences at the 6p22 end flanked a short stretch of 10 bases shared by the 6p22 and 14q32 ends, suggesting that a deletion or a looping-Alu mediated mispairing mechanism may lead to this chromosome translocation.
RESULTS: Northern blot and real-time polymerase chain reaction analyses showed that the Id4 mRNA was abnormally overexpressed in this case. Only the two smaller Id4 mRNA products were detected (1.6 and 1.1 kb). Immunohistochemical analysis of Id4 protein was also assayed in a series of hematologic malignancies. Marked overexpression was found in two cases of T-cell prolymphocytic leukemias and in four B-cell lineage acute lymphoblastic leukemia including one case with the t(8;14) and another case with a p53 mutation. INTERPRETATION AND
CONCLUSIONS: The Id4 gene may behave as an oncogene in some human leukemias, perhaps through its capacity to sequester specific B-cell transcription factors. A genetic recombination between Alu-repeated sequences may not be the exclusive mechanism of generating pathogenic chromosomal translocations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969807

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  13 in total

1.  Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.

Authors:  Jan Harder; Michael J Müller; Matthias Fuchs; Vera Gumpp; Annette Schmitt-Graeff; Richard Fischer; Melanie Frank; Oliver Opitz; Jens Hasskarl
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 2.  Inhibitor of differentiation 4 (ID4): From development to cancer.

Authors:  Divya Patel; Derrick J Morton; Jason Carey; Mathew C Havrda; Jaideep Chaudhary
Journal:  Biochim Biophys Acta       Date:  2014-12-12

3.  A rare case of acute lymphoblastic leukemia in a patient with light chain (AL) amyloidosis treated with lenalidomide.

Authors:  Ranjit Nair; Shereen Gheith; Dan Popescu; Nicole M Agostino
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 4.  Paradoxical role of Id proteins in regulating tumorigenic potential of lymphoid cells.

Authors:  Sumedha Roy; Yuan Zhuang
Journal:  Front Med       Date:  2018-07-24       Impact factor: 4.592

5.  Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.

Authors:  Qiong Wu; Michèle J Hoffmann; Florian H Hartmann; Wolfgang A Schulz
Journal:  Mol Cancer       Date:  2005-05-05       Impact factor: 27.401

6.  ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro.

Authors:  Sarah Weiler; Jolaolu A Ademokun; John D Norton
Journal:  Mol Cancer       Date:  2015-02-03       Impact factor: 27.401

7.  Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Authors:  Jason P W Carey; Ananthi J Asirvatham; Oliver Galm; Tandeih A Ghogomu; Jaideep Chaudhary
Journal:  BMC Cancer       Date:  2009-06-07       Impact factor: 4.430

8.  Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells.

Authors:  Carolin Manthey; Demissew S Mern; Anja Gutmann; Anne J Zielinski; Corinna Herz; Silke Lassmann; Jens Hasskarl
Journal:  BMC Cell Biol       Date:  2010-01-14       Impact factor: 4.241

9.  Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN.

Authors:  Pankaj Sharma; Ashley Evans Knowell; Swathi Chinaranagari; Shravan Komaragiri; Peri Nagappan; Divya Patel; Mathew C Havrda; Jaideep Chaudhary
Journal:  Mol Cancer       Date:  2013-06-21       Impact factor: 27.401

10.  Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer.

Authors:  Pankaj Sharma; Swathi Chinaranagari; Divya Patel; Jason Carey; Jaideep Chaudhary
Journal:  Cancer Med       Date:  2012-08-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.